A Pilot Prospective Study of Refractory Solid Tumor Patients for NGS-Based Targeted Anticancer Therapy.

In conclusion, this study suggests that targeted therapy based on NGS test may be a good choice for improving the care of patients with refractory solid tumors.
PMID: 30448735 [PubMed - as supplied by publisher]

Source: Translational Oncology - November 15, 2018 Category: Cancer & Oncology Authors: Seol YM, Kwon CH, Lee SJ, Lee SJ, Choi Y, Choi YJ, Kim H, Park DY Tags: Transl Oncol Source Type: research